M

Maze Therapeutics

120 employees

Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2018

Funding rounds raised

Total raised

$191M

from 13 investors over 13 rounds

M

Maze Therapeutics raised $190M on January 10, 2022

Investors: NS Investment, General Catalyst, Casdin Capital, LLC, Foresite Capital, City Hill Ventures, Driehaus Capital Management LLC and Woodline Partners LP

M

Maze Therapeutics raised undisclosed on October 23, 2019

Investors: City Hill Ventures

M

Maze Therapeutics raised $191M on February 28, 2019

Investors: Casdin Capital, LLC, ARCH Venture Partners, GV, Third Rock Ventures and Foresite Capital

FAQ